The table below shows Aligos Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$2.83M
$741.00K
$965.00K
$311.00K
$1.25M
$1.06M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$23.35M
$23.94M
$13.98M
$14.50M
$16.77M
$21.10M
SG&A
ALGS annual revenue (10-K history)
Aligos Therapeutics, Inc. reported annual revenue of $2.19M for fiscal year 2025. That is down 39.5% from $3.61M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.